InvestorsHub Logo
Followers 27
Posts 2742
Boards Moderated 0
Alias Born 03/17/2017

Re: Martygx post# 24693

Friday, 07/13/2018 12:39:31 PM

Friday, July 13, 2018 12:39:31 PM

Post# of 233768
martygx- as usual, I sense your cynicism?

Reasons why I believe that the sum of new CYDY will be balanced and even accretive to current SH is as follows:

- They are not in a situation to weaken Company or Stock with a fraudulent alike transaction -> See GSAT (o8>
.. and if they would do such a deal, they will be dead for a long time.

- Staying BOD members holding a sizable stake agreed upon deal

- The breast cancer only market size is above $13B, only assuming of having an initial 1% penetration so far (posted in our blog)

- Pestell coming on board of management after being added to the new Scientific Advisory Board solves an outstanding issue of the company: Having a successful and popular figure leading its core business.

- Last but not least, the just received 55c convertible debt with 2 years interest rate marks a floor between 40c - 50c and they also knew about this deal of course (NDA).

Yes, until deal details are filed, we don't know.
But my assessment is that we are a lot below value here for sure.

When everything will be know, our price correction will happen immediately - on deal closing the latest.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News